MELISSA FANTON: Open Payments
NPI 1902998974 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 58 payments from 19 companies in 2025. Trend: 2023 $2,093 · 2024 $1,545 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $181 |
| Novo Nordisk Inc | 6 | $129 |
| Axsome Therapeutics, Inc. | 1 | $88 |
| Exact Sciences Corporation | 4 | $87 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| ABBVIE INC. | 3 | $65 |
| Amgen Inc. | 4 | $65 |
| Edwards Lifesciences Corporation | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
Products named: MOUNJARO, Auvelity, JARDIANCE, VOQUEZNA, Cologuard Collection Kit, Ozempic, XIFAXAN, SHINGRIX.
Industry payments across NY — which companies pay providers there.
